Annual D&A
$32.88 M
+$31.64 M+2553.83%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual depreciation & amortization is currently $32.88 million, with the most recent change of +$31.64 million (+2553.83%) on 31 December 2023. During the last 3 years, it has risen by +$32.79 million (+35640.22%). CPRX annual D&A is now at all-time high.CPRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$9.45 M
+$16.00 K+0.17%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly depreciation & amortization is currently $9.45 million, with the most recent change of +$16.00 thousand (+0.17%) on 30 September 2024. Over the past year, it has increased by +$883.00 thousand (+10.31%). CPRX quarterly D&A is now at all-time high.CPRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$37.46 M
+$883.00 K+2.41%
30 September 2024
Summary:
Catalyst Pharmaceuticals TTM depreciation & amortization is currently $37.46 million, with the most recent change of +$883.00 thousand (+2.41%) on 30 September 2024. Over the past year, it has increased by +$13.11 million (+53.82%). CPRX TTM D&A is now at all-time high.CPRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2553.8% | +10.3% | +53.8% |
| 3 y3 years | +10000.0% | +10000.0% | +10000.0% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
CPRX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5 years | at high | >+9999.0% | at high | +6277.1% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | +6277.1% | at high | >+9999.0% |
Catalyst Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.45 M(+0.2%) | $37.46 M(+2.4%) |
| June 2024 | - | $9.44 M(+0.1%) | $36.58 M(+2.4%) |
| Mar 2024 | - | $9.43 M(+3.1%) | $35.71 M(+8.6%) |
| Dec 2023 | $32.88 M(+2553.8%) | $9.14 M(+6.7%) | $32.88 M(+35.0%) |
| Sept 2023 | - | $8.57 M(-0.0%) | $24.35 M(+49.1%) |
| June 2023 | - | $8.57 M(+29.8%) | $16.34 M(+109.3%) |
| Mar 2023 | - | $6.60 M(+973.2%) | $7.80 M(+529.9%) |
| Dec 2022 | $1.24 M(+545.3%) | $615.00 K(+11.2%) | $1.24 M(+88.6%) |
| Sept 2022 | - | $553.00 K(+1394.6%) | $657.00 K(+386.7%) |
| June 2022 | - | $37.00 K(+8.8%) | $135.00 K(+4.7%) |
| Mar 2022 | - | $34.00 K(+3.0%) | $129.00 K(-32.8%) |
| Dec 2021 | $192.00 K(+108.7%) | $33.00 K(+6.5%) | $192.00 K(+7.9%) |
| Sept 2021 | - | $31.00 K(0.0%) | $178.00 K(+0.6%) |
| June 2021 | - | $31.00 K(-68.0%) | $177.00 K(+58.0%) |
| Mar 2021 | - | $97.00 K(+410.5%) | $112.00 K(+21.7%) |
| Dec 2020 | $92.00 K(+67.3%) | $19.00 K(-36.7%) | $92.00 K(-215.0%) |
| Sept 2020 | - | $30.00 K(-188.2%) | -$80.00 K(+89.6%) |
| June 2020 | - | -$34.00 K(-144.2%) | -$42.20 K(-171.9%) |
| Mar 2020 | - | $77.00 K(-150.3%) | $58.70 K(+6.5%) |
| Dec 2019 | $55.00 K(+44.7%) | -$153.00 K(-325.7%) | $55.10 K(-75.0%) |
| Sept 2019 | - | $67.80 K(+1.3%) | $220.60 K(+36.1%) |
| June 2019 | - | $66.90 K(-8.9%) | $162.10 K(+56.8%) |
| Mar 2019 | - | $73.40 K(+487.2%) | $103.40 K(+172.1%) |
| Dec 2018 | $38.00 K(-16.8%) | $12.50 K(+34.4%) | $38.00 K(+17.3%) |
| Sept 2018 | - | $9300.00(+13.4%) | $32.40 K(-9.7%) |
| June 2018 | - | $8200.00(+2.5%) | $35.90 K(-11.8%) |
| Mar 2018 | - | $8000.00(+15.9%) | $40.70 K(-10.9%) |
| Dec 2017 | $45.70 K(+5.3%) | $6900.00(-46.1%) | $45.70 K(-10.0%) |
| Sept 2017 | - | $12.80 K(-1.5%) | $50.80 K(+6.9%) |
| June 2017 | - | $13.00 K(0.0%) | $47.50 K(+9.7%) |
| Mar 2017 | - | $13.00 K(+8.3%) | $43.30 K(-0.5%) |
| Dec 2016 | $43.40 K(+25.8%) | $12.00 K(+26.3%) | $43.50 K(+15.7%) |
| Sept 2016 | - | $9500.00(+8.0%) | $37.60 K(-4.6%) |
| June 2016 | - | $8800.00(-33.3%) | $39.40 K(-0.5%) |
| Mar 2016 | - | $13.20 K(+116.4%) | $39.60 K(+14.8%) |
| Dec 2015 | $34.50 K | $6100.00(-46.0%) | $34.50 K(-5.2%) |
| Sept 2015 | - | $11.30 K(+25.6%) | $36.40 K(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $9000.00(+11.1%) | $32.30 K(+9.9%) |
| Mar 2015 | - | $8100.00(+1.3%) | $29.40 K(+10.5%) |
| Dec 2014 | $26.60 K(+18.2%) | $8000.00(+11.1%) | $26.60 K(+9.5%) |
| Sept 2014 | - | $7200.00(+18.0%) | $24.30 K(+6.6%) |
| June 2014 | - | $6100.00(+15.1%) | $22.80 K(+1.8%) |
| Mar 2014 | - | $5300.00(-7.0%) | $22.40 K(-0.4%) |
| Dec 2013 | $22.50 K(+106.4%) | $5700.00(0.0%) | $22.50 K(+15.4%) |
| Sept 2013 | - | $5700.00(0.0%) | $19.50 K(+18.2%) |
| June 2013 | - | $5700.00(+5.6%) | $16.50 K(+22.2%) |
| Mar 2013 | - | $5400.00(+100.0%) | $13.50 K(+23.9%) |
| Dec 2012 | $10.90 K(-74.5%) | $2700.00(0.0%) | $10.90 K(-32.3%) |
| Sept 2012 | - | $2700.00(0.0%) | $16.10 K(-23.0%) |
| June 2012 | - | $2700.00(-3.6%) | $20.90 K(-46.7%) |
| Mar 2012 | - | $2800.00(-64.6%) | $39.20 K(-8.4%) |
| Dec 2011 | $42.80 K(+66.5%) | $7900.00(+5.3%) | $42.80 K(+3.6%) |
| Sept 2011 | - | $7500.00(-64.3%) | $41.30 K(+3.3%) |
| June 2011 | - | $21.00 K(+228.1%) | $40.00 K(+58.1%) |
| Mar 2011 | - | $6400.00(0.0%) | $25.30 K(-1.6%) |
| Dec 2010 | $25.70 K(-14.9%) | $6400.00(+3.2%) | $25.70 K(-2.7%) |
| Sept 2010 | - | $6200.00(-1.6%) | $26.40 K(-4.0%) |
| June 2010 | - | $6300.00(-7.4%) | $27.50 K(-5.2%) |
| Mar 2010 | - | $6800.00(-4.2%) | $29.00 K(-4.0%) |
| Dec 2009 | $30.20 K(-7.9%) | $7100.00(-2.7%) | $30.20 K(-3.5%) |
| Sept 2009 | - | $7300.00(-6.4%) | $31.30 K(-2.8%) |
| June 2009 | - | $7800.00(-2.5%) | $32.20 K(-1.2%) |
| Mar 2009 | - | $8000.00(-2.4%) | $32.60 K(-0.6%) |
| Dec 2008 | $32.80 K(+107.6%) | $8200.00(0.0%) | $32.80 K(+1.5%) |
| Sept 2008 | - | $8200.00(0.0%) | $32.30 K(+17.5%) |
| June 2008 | - | $8200.00(0.0%) | $27.50 K(+25.6%) |
| Mar 2008 | - | $8200.00(+6.5%) | $21.90 K(+38.6%) |
| Dec 2007 | $15.80 K(+222.4%) | $7700.00(+126.5%) | $15.80 K(+95.1%) |
| Sept 2007 | - | $3400.00(+30.8%) | $8100.00(+72.3%) |
| June 2007 | - | $2600.00(+23.8%) | $4700.00(+123.8%) |
| Mar 2007 | - | $2100.00 | $2100.00 |
| Dec 2006 | $4900.00(+250.0%) | - | - |
| Dec 2005 | $1400.00(+250.0%) | - | - |
| Dec 2004 | $400.00 | - | - |
FAQ
- What is Catalyst Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual D&A year-on-year change?
- What is Catalyst Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly D&A year-on-year change?
- What is Catalyst Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM D&A year-on-year change?
What is Catalyst Pharmaceuticals annual depreciation & amortization?
The current annual D&A of CPRX is $32.88 M
What is the all time high annual D&A for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual depreciation & amortization is $32.88 M
What is Catalyst Pharmaceuticals annual D&A year-on-year change?
Over the past year, CPRX annual depreciation & amortization has changed by +$31.64 M (+2553.83%)
What is Catalyst Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of CPRX is $9.45 M
What is the all time high quarterly D&A for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly depreciation & amortization is $9.45 M
What is Catalyst Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, CPRX quarterly depreciation & amortization has changed by +$883.00 K (+10.31%)
What is Catalyst Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of CPRX is $37.46 M
What is the all time high TTM D&A for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM depreciation & amortization is $37.46 M
What is Catalyst Pharmaceuticals TTM D&A year-on-year change?
Over the past year, CPRX TTM depreciation & amortization has changed by +$13.11 M (+53.82%)